Genitourinary Cancer,Other Cancers Latest Update on LITESPARK-022 Phase-3 Study of Belzutifan and Pembrolizumab in ccRCC May 16, 2023
Genitourinary Cancer,Other Cancers SG Efficacy in Platinum- And CPI-Refractory mUC: TROPHY-U-01 Cohort 1 Final Results May 16, 2023
Genitourinary Cancer,Other Cancers Pembrolizumab Efficacy in Platinum-Ineligible Urothelial Carcinoma May 16, 2023
Genitourinary Cancer,Other Cancers Association of imAEs With Outcomes in mUC Treated With Durvalumab With or Without Tremelimumab May 15, 2023
Genitourinary Cancer,Other Cancers Rogaratinib Versus Chemotherapy for Metastatic Urothelial Carcinoma: FORT-1 Study May 15, 2023
Genitourinary Cancer,Other Cancers Pembrolizumab With Vibostolimab/Favezelimab for High-Risk BCG-Unresponsive NMIBC Patients May 15, 2023
Genitourinary Cancer,Other Cancers First-Line Pembrolizumab With or Without Chemotherapy for Advanced Urothelial Carcinoma May 15, 2023
Genitourinary Cancer,Other Cancers Pembrolizumab, Quavonlimab, and Lenvatinib in Treatment of ccRCC May 08, 2023
